Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Sponsored by University of California, San Francisco
About this study
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
Primary Aims: 1. To evaluate the feasibility of developing a histologic based registry for participants living with metastatic lobular breast cancer. 2. To understand the natural history, treatment patterns, and overall survival in patients with metastatic ILC using modern, real-world data. Secondary Aims: 1. To evaluate the correlation between imaging findings and disease progression. 2. To evaluate the correlation between ctDNA and disease progression. 3. To develop an ongoing platform for evaluating new imaging tools, tumor markers, and participant recruitment for clinical trials. Outline: Participants will be recruited to participate in the registry during a regularly scheduled clinic visit with their treating oncologist, and consented to participate at this time. At each evaluati…
Where this study is enrolling (2)
- I'm interested
University of California, San Francisco
San Francisco, California
- Call 877-632-6789
MD Anderson Cancer Center
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓1. Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
- ✓2. Age \>=18 years
- ✓3. Any receptor subtype.
- ✓4. Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion criteria
- ✕1. Stage I-III breast cancer.
- ✕2. Lack of lobular histology on tumor biopsy.
- ✕3. Other active cancer (prior treated cancer with no current evidence of disease is allowed).
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.